超声引导射频消融治疗肝脏恶性肿瘤302例肿瘤残留危险因素分析

doi:10.3969/j.issn.1007-3969.2014.02.007

中国癌症杂志 ›› 2014, Vol. 24 ›› Issue (2): 119-127.doi: 10.3969/j.issn.1007-3969.2014.02.007

超声引导射频消融治疗肝脏恶性肿瘤302例肿瘤残留危险因素分析

花永强,陈颢,孟志强,陈震,林钧华,刘鲁明,朱晓燕,沈晔华,王鹏,高惠峰,解婧

复旦大学附属肿瘤医院中西医结合科，复旦大学上海医学院肿瘤学系，上海 200032

出版日期:2014-02-28 发布日期:2014-03-07
通信作者: 陈颢　E-mail:chengkll@hotmail.com
基金资助:
国家自然科学基金资助项目(No：81173461；No：81072942；No：30901911)

Risk factors for 302 hepatic malignancies cases with residual tumor after ultrasound-guided radiofrequency ablation treatment

HUA Yong-qiang,CHEN Hao,MENG Zhi-qiang,CHEN Zhen,LIN Jun-hua,LIU Lu-min,ZHU Xiao-yan,SHEN Ye-hua,WANG Peng,GAO Hui-feng,XIE Jing

Department of Integrative Cancer, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China

Published:2014-02-28 Online:2014-03-07
Contact: CHEN Hao E-mail: chengkll@hotmail.com

摘要/Abstract

摘要：

背景与目的：射频消融(radiofrequencey ablation，RFA)是治疗原发性肝癌和部分转移性肝癌的有效的方法，本研究探讨肝脏恶性肿瘤RFA治疗后肿瘤残留的危险因素。方法：回顾性分析2010年1月—2013年3月复旦大学附属肿瘤医院收治的302例原发性肝癌和转移性肝癌患者共691个肝内病灶接受RFA治疗的临床资料，采用单因素和多因素Logistic Regression模型分析与RFA治疗后肿瘤残留有关的危险因素。结果：RFA治疗后272例(90.07%)患者的632个(91.46%)病灶完全消融，肿瘤残留率为8.54%。直径≤3 cm的肿瘤残留率为6.30%，3~5 cm为9.57%，>5 cm为28.57%；靠近肝内大血管和胆囊肿瘤残留率分别为17.14%和18.52%；联合其他局部治疗和未联合其他局部治疗的肿瘤残留率分别为7.02%和13.41%。多因素分析显示，肿瘤最大直径>5 cm(P=0.044)、靠近肝内大血管(P=0.039)和未联合其他局部治疗(P=0.001)是RFA治疗后肿瘤残留的独立危险因素。112例患者282个病灶最大直径3~5 cm，RFA治疗后肿瘤残留多因素分析显示，肿瘤靠近肝内大血管(P=0.014)、单针射频(P=0.047)和未联合其他局部治疗(P=0.023)是RFA治疗后肿瘤残留的独立危险因素。结论：超声引导的RFA治疗可以获得满意的消融效果，其中肿瘤靠近肝内大血管、肿瘤最大直径>5 cm和未联合其他局部治疗是肿瘤残留的独立危险因素，对于直径为3~5 cm的肿瘤，除靠近肝内大血管和未联合其他局部治疗外，单针射频也是肿瘤残留的独立危险因素，采用双针或多针治疗可以提高消融效率，降低肿瘤残留。

关键词: 肝脏肿瘤, 射频消融, 残留, 危险因素

Abstract:

Background and purpose: Radiofrequency ablation (RFA) is one of the effective treatment methods for primary liver cancer and metastatic liver cancer. The purpose of this study was to investigate the risk factors of residual tumor after RFA for hepatic malignancies. Methods: A total number of 302 hepatic malignancies cases with 691 tumors after ultrasound-guided RFA from Jan. 2010 to Mar. 2013 were retrospectively analyzed. Single factor and multi-factor Logistic regression model were used to analyze the risk factors of residual tumor after RFA. Results: Complete ablation cases were 90.07% (272/302) for patients and 91.46% (632/691) for tumors, and the ablation residual rate was 8.54%. Ablation residual rates for tumor ≤3 cm, 3-5 cm and >5 cm in diameter were 6.30%, 9.57% and 28.57%, for tumor close to the intrahepatic vascular and gallbladder were 17.14% and 18.52%, for with and without combination with other local treatments were 7.02% and 13.41%, respectively. Multivariate analysis showed that tumor size>5 cm (P=0.044), proximity to large vessel (P=0.039) and without combination with other local treatments (P=0.001) were independent risk factors for ablation residual. Multivariate analysis showed that tumor near the intrahepatic vascular (P=0.014), single needle RFA (P=0.047) and without combination with other local treatments (P=0.023) were independent ablation residua risk factors for tumors between 3-5 cm in maximum diameter. Conclusion: Ultrasoundguided RFA can achieve satisfactory ablation effect. Tumor close to the intrahepatic vascular, tumor diameter >5 cm and without combination with other local treatment act as the independent risk factors for ablation residual. For tumors between 3-5 cm in diameter, in addition to close to intrahepatic blood vessels and without combination with other local treatment, single needle RFA is also another independent risk factor for ablation residual, and double-needle or multineedle treatment can improve the ablation efficiency and reduce residual rate.

Key words: Liver tumors, Radiofrequency ablation (RFA), Ablation residual, Risk factors

花永强,陈颢,孟志强,陈震,林钧华,刘鲁明,朱晓燕,沈晔华,王鹏,高惠峰,解婧. 超声引导射频消融治疗肝脏恶性肿瘤302例肿瘤残留危险因素分析[J]. 中国癌症杂志, 2014, 24(2): 119-127.

HUA Yong-qiang,CHEN Hao,MENG Zhi-qiang,CHEN Zhen,LIN Jun-hua,LIU Lu-min,ZHU Xiao-yan,SHEN Ye-hua,WANG Peng,GAO Hui-feng,XIE Jing. Risk factors for 302 hepatic malignancies cases with residual tumor after ultrasound-guided radiofrequency ablation treatment[J]. China Oncology, 2014, 24(2): 119-127.

[1]	刘加葳, 李　丹, 翟　青. 乳腺癌患者化疗致肝损伤的危险因素分析[J]. 中国癌症杂志, 2021, 31(1): 52-62.
[2]	曹　威, 何英剑, 李金锋, 解云涛, 王天峰, 范　铁, 王歆光, 汪　星, 范照青. 超声引导下空芯针穿刺活检诊断的乳腺导管原位癌病理学低估的危险因素分析[J]. 中国癌症杂志, 2020, 30(3): 217-223.
[3]	丁平安, 杨沛刚, 田　园, 郭子阳, 郭洪海, 刘　洋, 张志栋, 王　冬, 李　勇, 赵　群. 探索淋巴结外侵犯对胃癌患者生存预后的影响（附2 386例报告）[J]. 中国癌症杂志, 2020, 30(12): 1017-1025.
[4]	肖佳龙, 郑　莹. 全球肺癌的流行及预防进展[J]. 中国癌症杂志, 2020, 30(10): 721-725.
[5]	马小开,黄建康,朱? 博 1，彭德峰,周? 锐,王圣应 . 228例甲状腺微小乳头状癌临床特征及颈部淋巴结转移危险因素分析[J]. 中国癌症杂志, 2019, 29(8): 590-594.
[6]	苗长丰,马云涛,王晓鹏,狐　鸣,杨晓军 . 胃癌高危因素评分模型构建及对筛查时机、方案选择的价值研究[J]. 中国癌症杂志, 2019, 29(7): 501-507.
[7]	刘晓雪,宇传华,周薇,等. 中国近30年间结直肠癌死亡趋势分析[J]. 中国癌症杂志, 2018, 28(3): 177-183.
[8]	肖金成,康鑫鑫,白淇文,等. 经肝动脉化疗栓塞联合射频消融治疗原发性肝细胞癌合并门静脉癌栓的预后影响因素分析[J]. 中国癌症杂志, 2018, 28(3): 222-228.
[9]	林雪丹,杨天兴,陶志华. 癌胚抗原和糖类抗原19-9对Ⅱ~Ⅲ期结肠癌复发的预测价值[J]. 中国癌症杂志, 2018, 28(11): 827-832.
[10]	孔令超,缪长虹,陈万坤,等. 多功能喉罩与气管插管在日间手术小细胞肝癌经皮射频消融术中的应用比较[J]. 中国癌症杂志, 2018, 28(1): 69-74.
[11]	韩立涛,渠　宁,史荣亮,等. 鼻咽癌放化疗后颈部淋巴结残留及复发的外科治疗综述[J]. 中国癌症杂志, 2017, 27(6): 505-509.
[12]	袁筑慧,王　洋,李　威. 经皮射频消融术治疗外科切除术后复发性肝细胞癌疗效分析[J]. 中国癌症杂志, 2017, 27(12): 959-963.
[13]	张顺康,郑磊贞,陈　刚,等. 乳腺癌新辅助化疗患者上肢淋巴水肿的危险因素分析[J]. 中国癌症杂志, 2017, 27(10): 815-821.
[14]	黄永高,王鹏程,王　嵩,等. Ⅰ、Ⅱ型食管胃连接处腺癌根治性切除[J]. 中国癌症杂志, 2016, 26(5): 458-461.
[15]	申丽华,张忠伟,朱　彪. 肿瘤并发静脉血栓形成196例临床分析[J]. 中国癌症杂志, 2016, 26(4): 338-345.

超声引导射频消融治疗肝脏恶性肿瘤302例肿瘤残留危险因素分析

Risk factors for 302 hepatic malignancies cases with residual tumor after ultrasound-guided radiofrequency ablation treatment

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价